Literature DB >> 22824735

Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies.

Susanne M Veltman-Verhulst1, Jacky Boivin, Marinus J C Eijkemans, Bart J C M Fauser.   

Abstract

BACKGROUND For a number of reasons, the results of previous meta-analyses may not fully reflect the mental health status of the average woman suffering from polycystic ovary syndrome (PCOS), or the causes of this distress. Our objective was to examine emotional distress and its associated features in women with PCOS. METHODS A comprehensive meta-analysis of comparative studies reporting measures of depression, anxiety or emotional-subscales of quality of life (emoQoL) was performed. PubMed, Embase, PsychInfo and the Cochrane trial register databases were searched up to November 2011 (see Supplementary Data for PUBMED search string). Unpublished data obtained through contact with authors were also included. The standardized mean difference (SMD) of distress scores was calculated. Subgroup analyses and meta-regression analysis of methodological and PCOS-related features were performed. RESULTS Twenty-eight studies (2384 patients and 2705 control women) were included. Higher emotional distress was consistently found for women with PCOS compared with control populations [main outcomes: depression: 26 studies, SMD 0.60 (95% confidence interval (CI) 0.47-0.73), anxiety: 17 studies, SMD of 0.49 (95% CI 0.36-0.63), emoQoL: 8 studies, SMD -0.66 (95% CI -0.92 to -0.41)]. However, heterogeneity was present (I(2) 52-76%). Methodological and clinical aspects only partly explained effect size variation. CONCLUSIONS Women with PCOS exhibit significantly more emotional distress compared with women without PCOS. However, distress scores mostly remain within the normal range. The cause of emotional distress could only partly be explained by methodological or clinical features. Clinicians should be aware of the emotional aspects of PCOS, discuss these with patients and refer for appropriate support where necessary and in accordance with patient preference.

Entities:  

Mesh:

Year:  2012        PMID: 22824735     DOI: 10.1093/humupd/dms029

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  45 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  Predictors of Depression in Iranian Women with Polycystic Ovarian Syndrome.

Authors:  Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh Charandabi; Tahereh Behroozi Lak; Fatemeh Aliasghari
Journal:  Community Ment Health J       Date:  2017-11-14

3.  Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.

Authors:  Nanette Santoro; Esther Eisenberg; J C Trussell; LaTasha B Craig; Clarisa Gracia; Hao Huang; Ruben Alvero; Peter Casson; Gregory Christman; Christos Coutifaris; Michael Diamond; Susan Jin; Richard S Legro; Randal D Robinson; William D Schlaff; Heping Zhang
Journal:  Hum Reprod       Date:  2016-07-07       Impact factor: 6.918

Review 4.  CLINICAL PRACTICE. Polycystic Ovary Syndrome.

Authors:  Christopher R McCartney; John C Marshall
Journal:  N Engl J Med       Date:  2016-07-07       Impact factor: 91.245

Review 5.  Female infertility, infertility-associated diagnoses, and comorbidities: a review.

Authors:  Brent Hanson; Erica Johnstone; Jessie Dorais; Bob Silver; C Matthew Peterson; James Hotaling
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

Review 6.  Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment.

Authors:  Laura G Cooney; Anuja Dokras
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

7.  Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis.

Authors:  Eleni A Greenwood; Kristine Yaffe; Melissa F Wellons; Marcelle I Cedars; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

8.  Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.

Authors:  Saman Tauqir; Momina Israr; Bushra Rauf; Muhammad Omar Malik; Syed Hamid Habib; Fawad Ali Shah; Muhammad Usman; Muhammad Asif Raza; Inayat Shah; Haroon Badshah; Ehtesham Ehtesham; Mohsin Shah
Journal:  Adv Ther       Date:  2021-05-28       Impact factor: 3.845

9.  Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS.

Authors:  Anuja Dokras; David B Sarwer; Kelly C Allison; Lauren Milman; Penny M Kris-Etherton; Allen R Kunselman; Christy M Stetter; Nancy I Williams; Carol L Gnatuk; Stephanie J Estes; Jennifer Fleming; Christos Coutifaris; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2016-06-02       Impact factor: 5.958

10.  Quality of Life in Infertile Women with Polycystic Ovary Syndrome: a Comparative Study.

Authors:  Iuliia Naumova; Camil Castelo-Branco; Iuliia Kasterina; Gemma Casals
Journal:  Reprod Sci       Date:  2020-11-19       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.